-
1
-
-
84885778326
-
-
Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2012. Available at:
-
Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2012. Available at: http://www.cibmtr.org.
-
-
-
Pasquini, M.C.1
Wang, Z.2
-
2
-
-
77951588418
-
Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
-
Bishop M.R., Alyea E.P., Cairo M.S., et al. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2010, 16:563-564.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 563-564
-
-
Bishop, M.R.1
Alyea, E.P.2
Cairo, M.S.3
-
3
-
-
77952580739
-
NCI first International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biological Considerations of Hematological Relapse Following Allogeneic Stem Cell Transplantation Unrelated to Graft-Versus-Tumor Effects: state of the science
-
Cairo M.S., Jordan C.T., Maley C.C., et al. NCI first International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biological Considerations of Hematological Relapse Following Allogeneic Stem Cell Transplantation Unrelated to Graft-Versus-Tumor Effects: state of the science. Biol Blood Marrow Transplant 2010, 16:709-728.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 709-728
-
-
Cairo, M.S.1
Jordan, C.T.2
Maley, C.C.3
-
4
-
-
77953587073
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation
-
Pavletic S.Z., Kumar S., Mohty M., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. Biol Blood Marrow Transplant 2010, 16:871-890.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 871-890
-
-
Pavletic, S.Z.1
Kumar, S.2
Mohty, M.3
-
5
-
-
77951149575
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-tumor/leukemia reaction
-
Miller J.S., Warren E.H., van den Brink M.R., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-tumor/leukemia reaction. Biol Blood Marrow Transplant 2010, 16:565-586.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 565-586
-
-
Miller, J.S.1
Warren, E.H.2
van den Brink, M.R.3
-
6
-
-
77954288771
-
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the Committee on Prevention of Relapse following Allogeneic Cell Transplantation for Hematologic Malignancies
-
Alyea E.P., DeAngelo D.J., Moldrem J., et al. NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the Committee on Prevention of Relapse following Allogeneic Cell Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant 2010, 16:1037-1069.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1037-1069
-
-
Alyea, E.P.1
DeAngelo, D.J.2
Moldrem, J.3
-
7
-
-
77955503223
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation, Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part I: methods, acute leukemias, and myelodysplastic syndromes
-
Erratum 16:1752
-
Kröger N., Bacher U., Bader P., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation, Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part I: methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant 2010, 16:1187-1211. Erratum 16:1752.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1187-1211
-
-
Kröger, N.1
Bacher, U.2
Bader, P.3
-
8
-
-
77956309607
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
-
Kröger N., Bacher U., Bader P., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation, part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant 2010, 16:1325-1346.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1325-1346
-
-
Kröger, N.1
Bacher, U.2
Bader, P.3
-
9
-
-
77957754106
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
-
Porter D.L., Alyea E.P., Antin J.H., et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2010, 16:1467-1503.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, pp. 1467-1503
-
-
Porter, D.L.1
Alyea, E.P.2
Antin, J.H.3
-
10
-
-
79952609273
-
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee
-
Bishop M.R., Alyea E.P., Cairo M.S., et al. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee. Biol Blood Marrow Transplant 2011, 17:443-454.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 443-454
-
-
Bishop, M.R.1
Alyea, E.P.2
Cairo, M.S.3
-
11
-
-
84863337617
-
Clonal architecture of secondary acute myeloid leukemia
-
Walter M.J., Shen D., Ding L., et al. Clonal architecture of secondary acute myeloid leukemia. NEngl J Med 2012, 366:1090-1098.
-
(2012)
NEngl J Med
, vol.366
, pp. 1090-1098
-
-
Walter, M.J.1
Shen, D.2
Ding, L.3
-
12
-
-
84862776906
-
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
-
Ding L., Ley T.J., Larson D.E., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012, 481:506-510.
-
(2012)
Nature
, vol.481
, pp. 506-510
-
-
Ding, L.1
Ley, T.J.2
Larson, D.E.3
-
13
-
-
84860709392
-
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma
-
IFM Investigators
-
Attal M., Lauwers-Cances V., Marit G., et al. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. NEngl J Med 2012, 366:1782-1791. IFM Investigators.
-
(2012)
NEngl J Med
, vol.366
, pp. 1782-1791
-
-
Attal, M.1
Lauwers-Cances, V.2
Marit, G.3
-
14
-
-
84860741191
-
Lenalidomide after stem-cell transplantation for multiple myeloma
-
McCarthy P.L., Owzar K., Hofmeister C.C., et al. Lenalidomide after stem-cell transplantation for multiple myeloma. NEngl J Med 2012, 366:1770-1781.
-
(2012)
NEngl J Med
, vol.366
, pp. 1770-1781
-
-
McCarthy, P.L.1
Owzar, K.2
Hofmeister, C.C.3
-
15
-
-
78649601394
-
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose- and schedule-finding study
-
de Lima M., Giralt S., Thall P.F., et al. Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose- and schedule-finding study. Cancer 2010, 116:5420-5431.
-
(2010)
Cancer
, vol.116
, pp. 5420-5431
-
-
de Lima, M.1
Giralt, S.2
Thall, P.F.3
-
16
-
-
84878945027
-
Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation
-
Schroeder T., Czibere A., Platzbecker U., et al. Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation. Leukemia 2013, 27:1229-1235.
-
(2013)
Leukemia
, vol.27
, pp. 1229-1235
-
-
Schroeder, T.1
Czibere, A.2
Platzbecker, U.3
-
17
-
-
78651290248
-
Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
-
Handgretinger R., Zugmaier G., Henze G., et al. Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia 2011, 25:181-184.
-
(2011)
Leukemia
, vol.25
, pp. 181-184
-
-
Handgretinger, R.1
Zugmaier, G.2
Henze, G.3
|